Electrophysiology Ablation Catheters Market Report 2017 – Medical Devices Pipeline Assessment

“The Latest Research Report Electrophysiology Ablation Catheters – Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Electrophysiology Ablation Catheters Market

GlobalData’s Medical Devices sector report, Electrophysiology Ablation Catheters – Medical Devices Pipeline Assessment, 2017″ provides an overview of Electrophysiology Ablation Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Ablation Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1339343

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Electrophysiology Ablation Catheters under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Electrophysiology Ablation Catheters and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to –

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Electrophysiology Ablation Catheters under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the products current stage of development, territory and estimated launch date

View Sample PDF @ https://www.marketresearchreports.biz/reports/1339343/electrophysiology-ablation-catheters-medical-devices-pipeline-assessment-2017-market-research-reports.pdf

Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 8

2 Introduction 9

2.1 Electrophysiology Ablation Catheters Overview 9

3 Products under Development 10

3.1 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 10

3.2 Electrophysiology Ablation Catheters – Pipeline Products by Segment 11

3.3 Electrophysiology Ablation Catheters – Pipeline Products by Territory 12

3.4 Electrophysiology Ablation Catheters – Pipeline Products by Regulatory Path 13

3.5 Electrophysiology Ablation Catheters – Pipeline Products by Estimated Approval Date 14

3.6 Electrophysiology Ablation Catheters – Ongoing Clinical Trials 15

4 Electrophysiology Ablation Catheters – Pipeline Products under Development by Companies 16

4.1 Electrophysiology Ablation Catheters Companies – Pipeline Products by Stage of Development 16

4.2 Electrophysiology Ablation Catheters – Pipeline Products by Stage of Development 18

5 Electrophysiology Ablation Catheters Companies and Product Overview 20

5.1 Ablacon Inc Company Overview 20

5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 Advanced Cardiac Therapeutics, Inc. Company Overview 21

5.2.1 Advanced Cardiac Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.3 Apama Medical, Inc. Company Overview 22

5.3.1 Apama Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 Biosense Webster Inc Company Overview 23

5.4.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.5 BioTex Inc Company Overview 27

5.5.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Boston Scientific Corp Company Overview 29

5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 Cardima, Inc. (Inactive) Company Overview 36

5.7.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 36

5.8 CardioFocus Inc Company Overview 38

5.8.1 CardioFocus Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.9 CardioNova Ltd Company Overview 39

5.9.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 39

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1339343

5.10 CathEffects LLC Company Overview 40

5.10.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 40

5.11 CathRx Ltd Company Overview 41

5.11.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

5.12 Columbia University Company Overview 44

5.12.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 44

5.13 Cordis Corp Company Overview 45

5.13.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.14 CryoTherapeutics Gmbh Company Overview 46

5.14.1 CryoTherapeutics Gmbh Pipeline Products & Ongoing Clinical Trials Overview 46

5.15 Epicardial Technologies Inc Company Overview 47

5.15.1 Epicardial Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.16 FocusStart LLC Company Overview 48

5.16.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.17 Interventional Imaging, Inc. Company Overview 49

5.17.1 Interventional Imaging, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.18 Iowa Approach Inc. Company Overview 50

5.18.1 Iowa Approach Inc. Pipeline Products & Ongoing Clinical Trials Overview 50

5.19 Maestro Heart SA Company Overview 53

5.19.1 Maestro Heart SA Pipeline Products & Ongoing Clinical Trials Overview 53

5.20 Mayo Clinic US Company Overview 54

5.20.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 54

5.21 Medlumics SL Company Overview 55

5.21.1 Medlumics SL Pipeline Products & Ongoing Clinical Trials Overview 55

5.22 Medtronic plc Company Overview 56

5.22.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56

5.23 MedWaves Inc Company Overview 60

5.23.1 MedWaves Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.24 MicroPort Scientific Corp Company Overview 61

5.24.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 61

5.25 North Carolina State University Company Overview 63

5.25.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 63

5.26 Northwestern University Company Overview 64

5.26.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 64

5.27 SCR, Inc. Company Overview 65

5.27.1 SCR, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65

5.28 St. Jude Medical LLC Company Overview 66

5.28.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 66

5.29 Stereotaxis Inc Company Overview 68

5.29.1 Stereotaxis Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.30 Strategic Polymer Sciences, Inc Company Overview 69

5.30.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.31 University of Michigan Company Overview 70

5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 70

5.32 University of Rochester Company Overview 71

5.32.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 71

5.33 University of Texas Medical Branch at Galveston Company Overview 72

5.33.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 72

5.34 Vanderbilt University Company Overview 73

5.34.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 73

5.35 Vimecon GmbH Company Overview 74

5.35.1 Vimecon GmbH Pipeline Products & Ongoing Clinical Trials Overview 74

5.36 Vivonics, Inc. Company Overview 75

5.36.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75

5.37 Voyage Medical (Inactive) Company Overview 76

5.37.1 Voyage Medical (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 76

6 Electrophysiology Ablation Catheters- Recent Developments 77

6.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 77

6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 78

6.3 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 81

6.4 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81

6.5 Aug 01, 2017: FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization 82

6.6 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 83

6.7 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 85

6.8 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 86

6.9 Jul 11, 2017: Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation 86

6.10 Jul 07, 2017: MPSC New COO Glendy Wang on Board 87

6.11 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 87

6.12 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 89

6.13 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 90

6.14 May 23, 2017: MicroPort EP Obtains Thailand FDA Approval for FireMagic 3D Irrigated Ablation Catheter 93

6.15 May 23, 2017: MicroPort EP Obtains Thailand FDA Approval for FireMagic Cardiac RF Ablation Catheter 93

6.16 May 09, 2017: Abbott Announces CE Mark for TactiCath Contact Force Ablation Catheter, Sensor Enabled 93

6.17 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 95

6.18 Apr 27, 2017: Medtronic Expands Pain Therapies Portfolio with the Launch of OsteoCool RF Ablation System 96

6.19 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 96

6.20 Apr 23, 2017: Bard Announces First Quarter Results 97

6.21 Mar 30, 2017: Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation 98

6.22 Mar 30, 2017: MPSC Announces 2016 Annual Results 99

6.23 Mar 21, 2017: Texas Cardiac Arrhythmia Institute at St. David’s Medical Center First in Texas and Among First in U.S. to Use FlexAbility Ablation Catheter, Sensor Enabled 100

6.24 Mar 10, 2017: FireMagic Cardiac RF Ablation Catheter Gains MFDS Approval 101

6.25 Mar 01, 2017: Abbott Announces FDA Approval Of Flexability Ablation Catheter, Sensor Enabled To Advance The Treatment Of Complex Cardiac Arrhythmias 102

6.26 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 102

6.27 Feb 16, 2017: FDA Approves Expanded Indication for Medtronic Freezor Xtra Cryoablation Catheter 105

6.28 Feb 15, 2017: Medtronic’s OsteoCool RF Ablation System Receives Expanded Indication for Palliative Treatment of Metastatic Bone Tumors 106

6.29 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 107

6.30 Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 107

6.31 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 109

6.32 Jan 26, 2017: Bard Announces Fourth Quarter Results 110

6.33 Jan 19, 2017: CardioFocus Announces Initial Clinical Evaluation of Next-Generation HeartLight Excalibur Balloon Designed For the Treatment of Atrial Fibrillation 111

6.34 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 112

6.35 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 115

6.36 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 115

6.37 Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 116

6.38 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 118

6.39 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 118

6.40 Oct 25, 2016: Bard Announces Third Quarter Results 120

6.41 Oct 19, 2016: FireMagic Cool Catheter Obtains CFDA Approval 120

6.42 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 121

6.43 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 123

6.44 Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 123

7 Appendix 125

7.1 Methodology 125

7.2 About GlobalData 128

7.3 Contact Us 128

7.4 Disclaimer 128

Buy Now This Report From Here @ https://www.researchmoz.com/checkout?rep_id=1339343&licType=S

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net